# Benitec Biopharma Inc.: Form 8-K, filed Sep 24, 2026

- Company: [Benitec Biopharma Inc.](/companies/bntc.md) (CIK 1808898)
- Form: 8-K
- Filed: 2026-09-24
- Accepted by EDGAR: Sep 24, 2026, 16:38 ET
- Period: 2026-09-18
- Accession: 0001193125-26-401110
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808898/000119312526401110/bntc-20260918.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808898/000119312526401110/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808898/000119312526401110/bntc-20260918.htm

Filed Sep 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-401110. Last ingested by Listed: Nov 14, 2026, 11:28 ET. No prices; not investment advice.